aceRNA Technologies Co., Ltd.
PrivateLast Round
Series B
May 7, 2024
Total Funding Raised
$14.05M
Company Overview
aceRNA Technologies Co., Ltd. is a biotechnology company that develops mRNA-based and gene therapies using proprietary RNA Switch technology for cell-specific therapeutic expression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
aceRNA Technologies Co., Ltd. Comparables
Compare aceRNA Technologies Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Radar Therapeutics | 84% | |
| Combined Therapeutics | 83% | |
| Rgenta Therapeutics | 80% |
aceRNA Technologies Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 7, 2024 | ||||
| Series B | Dec 20, 2021 | ||||
| Series A | Oct 31, 2019 | ||||
| Seed | Nov 8, 2018 |
aceRNA Technologies Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCI Partners Co., Ltd. | Series B |
| Mitsubishi UFJ Capital | Series B |
| Kyoto University Innovation Capital | Seed, Series A |
| SMBC Venture Capital | Series A |
| UTokyo Innovation Platform Co., Ltd. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 114% MoM.
- Mar 2, 2026
Monthly visitors grew 100% MoM, reaching 2.4K.
aceRNA Technologies Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about aceRNA Technologies Co., Ltd.'s valuation, stock price, and market status.
Is aceRNA Technologies Co., Ltd. a public or private company?
aceRNA Technologies Co., Ltd. is a private company.
What is the current stock price of aceRNA Technologies Co., Ltd.?
aceRNA Technologies Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is aceRNA Technologies Co., Ltd. worth (valuation)?
Valuation information for aceRNA Technologies Co., Ltd. is not publicly available.
Can I buy aceRNA Technologies Co., Ltd. stock?
aceRNA Technologies Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was aceRNA Technologies Co., Ltd.'s last funding round?
aceRNA Technologies Co., Ltd.'s most recent funding round was Series B on May 7, 2024.
Who are the main investors in aceRNA Technologies Co., Ltd.?
Key investors in aceRNA Technologies Co., Ltd. include DCI Partners Co., Ltd., Kyoto University Innovation Capital.
Will aceRNA Technologies Co., Ltd. IPO soon?
No public IPO plans have been announced for aceRNA Technologies Co., Ltd..
How can I track aceRNA Technologies Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor aceRNA Technologies Co., Ltd.'s secondary market activity and sign up for updates.